SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical […]
Fourth Quarter Highlights Organic growth of 9.4% year-over-year in Broadcast and Recurring Commercial Music Revenues; Revenues improved 6.0% to $83.7 […]